{
    "diagnosis_als_gsd_category_1": {
        "description": "Indicates the participant's ALS diagnosis under GSD category 1.",
        "question": {
            "en": "(1) Progressive motor impairment documented by history or repeated clinical assessment, preceded by normal motor function;"
        },
        "datatype": [
            "xsd:string"
        ],
        "choices": [
            {
                "name": {
                    "en": "Yes "
                },
                "value": "yes"
            },
            {
                "name": {
                    "en": "No "
                },
                "value": " no"
            },
            {
                "name": {
                    "en": "Not certain"
                },
                "value": " notCertain"
            }
        ]
    },
    "diagnosis_als_gsd_category_2": {
        "description": "Indicates if the participant meets the criteria for ALS GSD Category 2.",
        "question": {
            "en": "(2) presence of UMN and LMN signs in at least 1 body region (with UMN and LMN dysfunction noted in the same body region if only one body region is involved) or LMN dysfunction in at least 2 body regions;"
        },
        "datatype": [
            "xsd:string"
        ],
        "choices": [
            {
                "name": {
                    "en": "Yes "
                },
                "value": "yes"
            },
            {
                "name": {
                    "en": "No "
                },
                "value": " no"
            },
            {
                "name": {
                    "en": "Not certain"
                },
                "value": " notCertain"
            }
        ]
    },
    "diagnosis_als_gsd_category_3": {
        "description": "Indicates the participant's ALS diagnosis under GSD category 3.",
        "question": {
            "en": "(3) investigations excluding other disease processes."
        },
        "datatype": [
            "xsd:string"
        ],
        "choices": [
            {
                "name": {
                    "en": "Yes "
                },
                "value": "yes"
            },
            {
                "name": {
                    "en": "No "
                },
                "value": " no"
            },
            {
                "name": {
                    "en": "Not certain"
                },
                "value": " notCertain"
            }
        ]
    },
    "diagnosis_als_gsd_calculation": {
        "description": "Calculation for the participant's ALS GSD diagnosis.",
        "question": {
            "en": "Does the patient meet the diagnostic criteria for Amyotrophic Lateral Sclerosis (ALS) based on the criteria above?"
        },
        "datatype": [
            "xsd:string"
        ],
        "choices": null
    },
    "diagnosis_als_disease_subtype": {
        "description": "Indicates the subtype of ALS diagnosed in the participant."
    },
    "diagnosis_als_disease_subtype_familial": {
        "description": "Indicates if the participant has been diagnosed with familial ALS.",
        "question": {
            "en": "If you selected \"Familial ALS\", please specify the genetic mutation if known:"
        },
        "datatype": [
            "xsd:string"
        ],
        "choices": null
    },
    "diagnosis_als_etiology___genetic_factors": {
        "description": "Indicates if the participant's ALS diagnosis is linked to genetic factors."
    },
    "diagnosis_als_etiology___environmental_factors": {
        "description": "Indicates if the participant's ALS diagnosis is linked to environmental factors."
    },
    "diagnosis_als_etiology_genetic_factors___c9orf72": {
        "description": "Indicates if the participant's ALS diagnosis is linked to the C9orf72 genetic factor."
    },
    "diagnosis_als_etiology_genetic_factors___sod1": {
        "description": "Indicates if the participant's ALS diagnosis is linked to the SOD1 genetic factor."
    },
    "diagnosis_als_etiology_genetic_factors___other": {
        "description": "Indicates if the participant's ALS diagnosis is linked to other genetic factors not listed."
    },
    "diagnosis_als_cp___upper_motor_neuron": {
        "description": "Indicates if the participant's ALS diagnosis includes upper motor neuron involvement."
    },
    "diagnosis_als_cp___lower_motor_neuron": {
        "description": "Indicates if the participant has lower motor neuron involvement as part of their ALS diagnosis."
    },
    "diagnosis_als_cp___bulbar_symptoms": {
        "description": "Indicates if the participant has bulbar symptoms as part of their ALS diagnosis."
    },
    "diagnosis_als_cp___respiratory_involvement": {
        "description": "Indicates if the participant has respiratory involvement as part of their ALS diagnosis."
    },
    "diagnosis_als_dp": {
        "description": "Indicates if the participant has a diagnosis of ALS with dementia.",
        "question": {
            "en": "Please provide information on the current stage and progression of ALS:"
        },
        "datatype": [
            "xsd:string"
        ],
        "choices": [
            {
                "name": {
                    "en": "Early Stage "
                },
                "value": "earlyStage"
            },
            {
                "name": {
                    "en": "Intermediate Stage "
                },
                "value": " intermediateStage"
            },
            {
                "name": {
                    "en": "Advanced Stage"
                },
                "value": " advancedStage"
            }
        ]
    },
    "diagnosis_als_na_alsfrs_r_score": {
        "description": "The participant's score on the ALS Functional Rating Scale-Revised (ALSFRS-R).",
        "question": {
            "en": "Revised ALS Functional Rating Scale (ALSFRS-R) score:"
        },
        "datatype": [
            "xsd:string"
        ],
        "choices": null
    },
    "diagnosis_als_na_fvc_percentage": {
        "description": "Indicates the participant's forced vital capacity (FVC) percentage for ALS diagnosis.",
        "question": {
            "en": "Forced Vital Capacity (FVC) percentage (if measured):"
        },
        "datatype": [
            "xsd:string"
        ],
        "choices": null
    },
    "diagnosis_als_treatment_and_management": {
        "description": "Indicates the treatment and management plan for the participant's ALS diagnosis."
    },
    "diagnosis_als_treatment_and_management_yes___medications": {
        "description": "Indicates if the participant is receiving medications as part of ALS treatment."
    },
    "diagnosis_als_treatment_and_management_yes___supportive_care": {
        "description": "Indicates if the participant is receiving supportive care as part of ALS management."
    },
    "diagnosis_als_treatment_and_management_yes_medications___riluzole": {
        "description": "Indicates if the participant is receiving riluzole as part of ALS treatment."
    },
    "diagnosis_als_treatment_and_management_yes_medications___edaravone": {
        "description": "Indicates if the participant is receiving edaravone as part of ALS treatment."
    },
    "diagnosis_als_treatment_and_management_yes_medications___sodium": {
        "description": "Indicates if the participant is receiving sodium as part of ALS treatment."
    },
    "diagnosis_als_treatment_and_management_yes_medications___tofersen": {
        "description": "Indicates if the participant is receiving Tofersen as part of ALS treatment."
    },
    "diagnosis_als_treatment_and_management_yes_medications___symptomatic_treatment": {
        "description": "Indicates if the participant is receiving symptomatic treatment as part of ALS management."
    },
    "diagnosis_als_treatment_and_management_yes_medications___other": {
        "description": "Indicates if the participant is receiving other medications as part of ALS treatment."
    },
    "diagnosis_als_treatment_and_management_yes_supportive_care___physical_therapy": {
        "description": "Indicates if the participant has received physical therapy as part of ALS management."
    },
    "diagnosis_als_treatment_and_management_yes_supportive_care___occupational_therapy": {
        "description": "Indicates if the participant is receiving occupational therapy as part of ALS treatment and supportive care."
    },
    "diagnosis_als_treatment_and_management_yes_supportive_care___speech_therapy": {
        "description": "Indicates if the participant has received speech therapy as part of ALS management."
    },
    "diagnosis_als_treatment_and_management_yes_supportive_care___respiratory_support": {
        "description": "Indicates if the participant has received respiratory support as part of ALS management."
    },
    "diagnosis_als_treatment_and_management_yes_supportive_care___nutrition_support": {
        "description": "Indicates if the participant has received nutrition support as part of ALS management."
    },
    "diagnosis_als_treatment_and_management_yes_supportive_care___psychotherapy": {
        "description": "Indicates if the participant has received psychotherapy as part of ALS management."
    },
    "diagnosis_als_treatment_and_management_yes_supportive_care___other": {
        "description": "Indicates if the participant has received other forms of supportive care for ALS."
    },
    "data_elements": {}
}
